Department of Obstetrics and Gynaecology

HLA-G expression associates with immune evasion muscle-invasive urothelial cancer and drives prognostic relevance () Branz A, Matek C, Lange F, Bahlinger V, Klümper N, Hölzel M, Strissel P, et al. Journal article Germline variants of homology-directed repair or mismatch repair genes in cervical cancer () Kokemüller L, Ramachandran D, Schürmann P, Geffers R, Jentschke M, Böhmer G, Strauß HG, et al. Journal article Feasibility of virtual T2-weighted fat-saturated breast MRI images by convolutional neural networks (2025) Liebert A, Hadler D, Ehring C, Schreiter H, Brock L, Kapsner L, Eberle J, et al. Journal article Attitudes of female carriers of X-linked hypohidrotic ectodermal dysplasia towards prenatal treatment and their decisions during a pregnancy with a male fetus (2025) Schneider H, Schneider M, Lia M, Grange DK, Hadj-Rabia S, Clarke A, Fete M, et al. Journal article Effect of delayed isolation of peripheral blood mononuclear cells on cell viability and functionality (2025) Lehle S, Völkl S, Seitz K, Goossens C, Emons J, Rübner M, Uhrig S, et al. Journal article Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer (2025) Hoppe R, Winter S, Lo WY, Michailidou K, Bolla MK, Keeman R, Wang Q, et al. Journal article Correction to: Gender-affirming hormonal therapy induces a gender-concordant fecal metagenome transition in transgender individuals (BMC Medicine, (2024), 22, 1, (346), 10.1186/s12916-024-03548-z) (2025) Liwinski T, Auer MK, Schröder J, Pieknik I, Casar C, Schwinge D, Henze L, et al. Journal article, Erratum Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer (2025) Michel LL, Ziegler P, Kreis P, Hartkopf AD, Wallwiener M, Häberle L, John N, et al. Journal article Risk for non-sentinel metastases in the contralateral groin in patients with a unilateral positive sentinel lymph node in primary vulvar cancer- a subgroup analysis of the AGO-VOP.2 QS Vulva Study (2025) Jaeger A, Hampl M, Prieske K, Eulenburg C, Reichenbach J, Klapdor R, Heublein S, et al. Journal article GWAS meta-analysis identifies five susceptibility loci for endometrial cancer (2025) Ramachandran D, Wang X, Laisk T, Zheng Y, Ingold N, Canson DM, Kho PF, et al. Journal article